Pfizer Says Hospira Purchase Will Close in Early September

August 24, 2015 3:22 PM

36 0

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.

The New York company said Monday regulators in the U.S. and Brazil cleared the deal. European Union regulators approved it earlier this month, as did antitrust agencies in Canada and Australia.

Also read: AT&T’s $85.4B deal for Time Warner: A new bet on synergy

Read more

To category page